Cannabis consumers have long prized potency (a high THC content) as one of the main factors that makes a particular strain more desirable. Though traditional demand for THC has caused an oversaturation of high-potency products, many consumers are starting to prefer less intense products that are lower in THC and higher in the non-intoxicating compound called cannabidiol (CBD).
A. While the agency is aware of reports of pets consuming various forms of marijuana, to date, FDA has not directly received any adverse event reports associated with giving marijuana to animals via our safety reporting portals. However, adverse events from accidental ingestion are well-documented in scientific literature. If you feel your animal has suffered from ingesting marijuana, we encourage you to report the adverse event to the FDA. Please visit Reporting Information about Animal Drugs and Devices to learn more about how to report an adverse event related to an animal food or drug.
The 2014 Farm Bill legalized the sale of "non-viable hemp material" grown within states participating in the Hemp Pilot Program. This legislation defined hemp as cannabis containing less than 0.3% of THC delta-9, grown within the regulatory framework of the Hemp Pilot Program. The 2018 Farm Bill allowed for interstate commerce of hemp derived products, though these products still fall under the purview of the FDA.
¿Que qué es el CBD? Literalmente: cannabidiol. O sea, el cannabioide principal componente de la planta del cannabis (representa hasta un 40% de sus extractos). Pero, espera, porque no es psicoactivo ni intoxicante, sino que se utiliza para aplicaciones médicas y para conseguir un efecto sedante. Así que sí: puede evitar el dolor de pies por los altos tacones, relajar tus músculos o incluso paliar el dolor de enfermedades como la artritis.
Still, as the saying goes, absence of evidence isn’t necessarily evidence of absence, and there’s a reason we don’t have a ton of solid research on CBDs yet — “to study it, we need a good source, ” said Ziva Cooper, who is an associate professor at Columbia University and was on the National Academies committee. CBD is hard to get because it’s still technically a Schedule I drug, which limits its availability, Cooper said.
Hay una excepción: pruebas de un aceite médico de cannabidiol (también conocido como CBD) llamado Epidiolex demuestran que puede reducir las convulsiones provocadas por ciertos tipos de epilepsia. Un comité de la Administración de Medicamentos y Alimentos de Estados Unidos (FDA, por sus siglas en inglés) recomendó esta semana aprobar a Epidiolex como nuevo medicamento.